Secondary Endosymbiosis Exposed

Photo: Nils Kroger, Regensburg UniversityLast summer's publication of the first diatom genome provided insight into the workings of a tiny organism with huge potential for environmental, industrial, and research applications.1 A growing appreciation of the sequence, however, has begun to divulge one of nature's wilder and most productive experiments.Diatoms, a diverse division of one-celled ocean algae with gemlike silica casings, are thought to collectively absorb as much carbon dioxide through

Written byJack Lucentini
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Photo: Nils Kroger, Regensburg University

Last summer's publication of the first diatom genome provided insight into the workings of a tiny organism with huge potential for environmental, industrial, and research applications.1 A growing appreciation of the sequence, however, has begun to divulge one of nature's wilder and most productive experiments.

Diatoms, a diverse division of one-celled ocean algae with gemlike silica casings, are thought to collectively absorb as much carbon dioxide through photosynthesis as all the world's rainforests. They appear to have descended from organisms near the plant-animal divergence in evolution, and their unique and intricate structures serve both as inspiration and model for nanofabrication technologies.

Yet beneath their sometimes striking enclosures, diatoms and many other algae reveal a sordid past of endosymbiotic events. They are, in essence, three organisms in one – or more precisely, one within another, within another. Researchers say this odd arrangement has major implications for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies